Neurotoxic side effects of acyclovir: two case reports.

Pub Date : 2021-10-01
Zoltan Paluch, Milan Trojánek, Zuzana Velíšková, Jana Mlíchová, Pavel Chrbolka, Jana Gregorová, Emanuel Marques, Dagmar Kalatova, Dušan Pícha
{"title":"Neurotoxic side effects of acyclovir: two case reports.","authors":"Zoltan Paluch,&nbsp;Milan Trojánek,&nbsp;Zuzana Velíšková,&nbsp;Jana Mlíchová,&nbsp;Pavel Chrbolka,&nbsp;Jana Gregorová,&nbsp;Emanuel Marques,&nbsp;Dagmar Kalatova,&nbsp;Dušan Pícha","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Acyclovir is an antiviral drug frequently used in clinical practice. It is indicated for the treatment of infections caused by herpes simplex virus and varicella zoster virus. The drug has a good safety profile; however, severe side effects may rarely occur during therapy. These include renal failure as a major risk factor for neurotoxic side effects potentially developing within 24-48 hours of therapy initiation. The paper presents the cases of two patients developing neurotoxic side effects while treated for herpes zoster. The aim of the authors is to highlight the potential for developing neurotoxic side effects in high-risk groups such as the elderly, patients with impaired renal function or multiple comorbidities on polypharmacy, or those using nephrotoxic drugs. Acyclovir use could lead to renal impairment and an increase in its plasma and CNS concentrations with severe neuropsychiatric side effects. The neurotoxic side effects are reversible after therapy withdrawal. Thus, in patients developing mental impairment or showing other neurological symptoms during acyclovir therapy, the patient should be promptly assessed for potential drug neurotoxicity, their therapy should be discontinued and drug elimination with forced diuresis or hemodialysis considered. Early recognition of acyclovir neurotoxic side effects can significantly improve a patient's prognosis.</p>","PeriodicalId":0,"journal":{"name":"","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"3","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Acyclovir is an antiviral drug frequently used in clinical practice. It is indicated for the treatment of infections caused by herpes simplex virus and varicella zoster virus. The drug has a good safety profile; however, severe side effects may rarely occur during therapy. These include renal failure as a major risk factor for neurotoxic side effects potentially developing within 24-48 hours of therapy initiation. The paper presents the cases of two patients developing neurotoxic side effects while treated for herpes zoster. The aim of the authors is to highlight the potential for developing neurotoxic side effects in high-risk groups such as the elderly, patients with impaired renal function or multiple comorbidities on polypharmacy, or those using nephrotoxic drugs. Acyclovir use could lead to renal impairment and an increase in its plasma and CNS concentrations with severe neuropsychiatric side effects. The neurotoxic side effects are reversible after therapy withdrawal. Thus, in patients developing mental impairment or showing other neurological symptoms during acyclovir therapy, the patient should be promptly assessed for potential drug neurotoxicity, their therapy should be discontinued and drug elimination with forced diuresis or hemodialysis considered. Early recognition of acyclovir neurotoxic side effects can significantly improve a patient's prognosis.

分享
阿昔洛韦的神经毒性副作用:两例报告。
无环鸟苷是临床常用的抗病毒药物。适用于单纯疱疹病毒和水痘带状疱疹病毒引起的感染。该药物具有良好的安全性;然而,严重的副作用可能很少发生在治疗期间。其中包括肾衰竭,这是在治疗开始24-48小时内可能发生的神经毒性副作用的主要危险因素。本文介绍了两例患者在治疗带状疱疹时出现神经毒性副作用的病例。作者的目的是强调在高危人群中可能产生神经毒性副作用,如老年人、肾功能受损患者或多种合并症患者,或使用肾毒性药物的患者。使用阿昔洛韦可导致肾功能损害,血浆和中枢神经系统浓度增加,并伴有严重的神经精神副作用。神经毒性副作用在停药后是可逆的。因此,对于在阿昔洛韦治疗期间出现精神障碍或出现其他神经系统症状的患者,应及时评估其潜在的药物神经毒性,应停止治疗,并考虑通过强制利尿或血液透析来消除药物。早期识别阿昔洛韦的神经毒性副作用可以显著改善患者的预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信